Congress 101

Watch with Us: Congress Hears from Patients about Affordable Drug Pricing

This week, both the House and Senate will tackle the issue of drug pricing- and they’ll be hearing from patients. In a House Energy and Commerce Subcommittee hearing on Wednesday morning at 10am, officials will hear testimony on the drug supply chain, specifically how ‘middle men’ like wholesalers, distributors, and payers impact affordable access to prescription drugs. (Politico)

For the first time, Congress will hear patient voices alongside industry leaders.

David Mitchell, the Founder and President of Patients for Affordable Drugs will present patient stories he has collected, including his own experience with cancer medications, alongside facts and figures on drug pricing at the Wednesday hearing. The Senate also heard from Mitchell on Tuesday, when they reviewed the National Academy of Medicine’s November report on making medicines more affordable. (Politico)

Watch the hearing along with us here! Then say what are you hoping will be the outcome from this meeting in the comments below! DPAC will be following along and posting what impact the hearing could have on people with diabetes in the upcoming days.

 

US Constitution Bill-to-law

Bills-to-Laws: Changing Federal Diabetes Health Policy

We’ve all seen the SchoolHouse Rock video. (If you haven’t…)

We wish it were as simple as a cartoon, but it’s not.

The bills-to-laws process is a vital part of policy-making and policy changing within the U.S. government. However, the legislative branch of the Congress, consisting of the House of Representatives and Senate, will see thousands of bills introduced in this 115th United States Congress. Only 10% of these bills will become laws and make it through the entire process.

Let’s take the bill, H.R. 3271, the “Protecting Access to Diabetes Supplies Act of 2017,”  as an example.

Bills-to-Laws: Where Do They Start?

legislationIt starts with an idea. Interested parties can ask for assistance to help better the U.S. public.

Any bill can be drafted by members of Congress (or the Executive Branch!), and groups outside the legislative or executive branches can even draft bills. The bill is then introduced by a member of Congress in the House of Representatives. H.R. 3271 was sponsored by Representative Diana DeGette of Colorado, and co-sponsored by Representatives Susan Brooks of Indiana, and Tom Reed of New York. As chairs and co-chairs of the Congressional Diabetes Caucus, these representatives assisted with drafting the bill and introducing H.R.3271 in the House.

From the House, the Speaker of the House sends the bill to a Committee to be heard. H.R. 3271 was sent to the Committee on Energy and Commerce, and to the Committee on Ways and Means in July of 2017, formerly with the purpose “To amend title XVIII of the Social Security Act in order to strengthen rules in case of competition for diabetic testing strips, and for other purposes.

After the Committee hearingthe Committee takes action on whether to amend, vote on, or take other actions on the bill. In the Committee hearing for H.R. 3271, the CEO of DPAC, Christel Aprigliano spoke before the Health Subcommittee of Energy and Commerce. She urged the members to enact this bill, which will help ensure beneficiaries with diabetes will not be switched from the meters they know and trust by mail order suppliers. The bill provides oversight and protection.

Most bills do not make it past the Committee phase, but if they do, they are sent on to the Rules Committee to determine specifications about carrying out the debate of the bill. From here, the legislation is placed on the calendar for Floor Action. In this stage, the House of Representatives debates the bill via the rules from the Rules Committee, to be amended and voted on.

On to the Senate and Back to the House

bill-to-lawIf a majority votes in favor of the bill, the bill moves on to the Senate. The bill is then sent to another Committee, with the same process repeated as in the House with additional Committee Action. The bill can be talked about an unlimited amount by the Senate, where it often dies by a filibuster. If it does not die, the majority floor leader then decides if the whole Senate will vote on the bill. The Senate then takes Floor Action to amend and debate the bill, and if a majority votes on it, then the bill goes back to the House.

Here, Conference Committees are formed by each house if the changes made to the bill by the Senate are contested. The compromise is then voted on by each house; if a majority votes in favor of the bill then it goes on to the President.

The Last Step

Finally, the President may approve or veto the bill, and an approved bill becomes a law. If the President decides to veto the bill, then two-thirds of both houses can vote to override the Presidential veto.

As you remember in the SchoolHouse Rock video, the steps can make “the bill” tired.

The bills-to-laws process is extremely complex and slow, involving extensive debate and discussion.

It’s up to us – the diabetes community who care about access to accurate and trusted supplies in diabetes management want “to strengthen rules in case of competition for diabetic testing strips, and for other purposes” through H.R. 3271 , we must contact our representatives now.

We must take action on H.R. 3271 in order to give this bill the greatest chance of becoming a law. Click the image and send your email now!

 

bill-to-law

Protect people with diabetes.

Contact your representatives today through DPAC.

Playing Policy Advocacy at Recess

Congress is coming home from Washington for a break – or a recess. The House calls it a “District Work Period.” Your Representative may be having a town hall or other public event to connect with constituents. If so, it is an excellent opportunity to share your views on diabetes and health policy.

What’s Your Member Doing for Recess?

Your member’s web page is a great place to find out what they have scheduled. Or you can call their office.  DPAC’s Scorecard lists every member of Congress’ web page and phone number.

Go to the Scorecard

  • Scroll Down to your State and Member
  • Click the “www” in your Member’s row for their website.
  • The DC office phone number is there too.
  • Scroll to the right and find out how many people in your district live with diabetes.

 


Write a question before you go. Start with a short introduction including:

  • Your hometown, so they know you are a constituent.
  • How many people in the district have diabetes, so they know there are a lot of us.
  • A specific question that touches your life, so the member’s reply address you as an individual.

Examples

Hi. I am Jane Doe from Hometown. I am one of 56 thousand people in the 5th district with diabetes. It is a pre-existing condition of us all. How are you protecting access to my doctor and the treatments she prescribes that me a useful and productive contributor to the community here in the 5th district?

or

Hi. I am Jane Doe from Hometown. My child is one of 56 thousand people in the 5th district with diabetes. Will you protecting her access to care through my insurance until she is 26 so she can see her doctor, stay a healthy and established herself as a young adult?

Get there early and get a good seat.

While You Are There

Even if you may not agree with your representative’s party or stand on a topic, it’s crucial to be polite during your interactions. Insulting or yelling at a representative is a sure way to shut down a productive conversation quickly.

Stick around.

  • Connect with staff and get their contact information.
  • Engage with local reporters.
  • Offer to be a resource and share your contact information.

What if They are Not Playing?

If you are not seeing that your Member of Congress is holding a town hall meeting, you can still connect.

  • Call the office and politely ask when the members will appear at a public event in the district.
  • Make an appointment at the local office to speak to staff.
  • Sign up for their newsletter to stay informed of your Members activities.
  • Ask your question through your member’s social media channels.

Happy Birthday, 115th Congress!

Every two years, a new Congress convenes, after a completely new House of Representatives and several new Senate members are selected to represent us. On January 3, 2017, the 115th Congress will convene at noon and will decide on bills, resolutions, and weigh in on our lives, liberties, and pursuits of happiness.

And diabetes. They’ll make decisions about diabetes, too.

Changes to Congress

Fifty-six new members will take seats in the House of Representatives (42 Republicans/ 14 Democrats) and three new Democratic Senators and one new Republican Senator rounds out the “freshman class.”

The 115th Congress will be represented by a Republican majority in both the Senate and the House; 104 women (/21 Senate83 House), with Cortez Masto a the first Latina to serve in the Senate. There was also an increase in minority representation: 59 African-American members, 38 Hispanic members, 15 Asian members, and 4 Indian-American members. While this is not representative of the United States population, this is a change from previous Congresses. For more information about the 115th Congress demographic makeup, the Hill has a brief, but helpful, article here.

Senate leadership will change, with Senator Charles Schumer (D-NY) assuming the role of minority leader from retiring Senator Harry Reid (D-NV).

Committees & Subcommittees

While nothing is etched in stone, some of the committees will see changes in leadership that will impact people with diabetes:

Energy & Commerce Committee leadership in the House is being handed over from Rep. Fred Upton (R-MI-06) to Rep. Greg Walden (R-OR-02), but no announcement has been made about the identity of the chairman of the health subcommittee of Energy & Commerce.

Senators Lamar Alexander (R-TN) and Patty Murray (D-WA) will remain as the leadership of the Senate Health, Education, Labor and Pensions (HELP) Committee. They will be instrumental in the passage of the successor of the National Diabetes Clinical Care Commission Act, which was passed in the House during the 114th Congress, but languished in the HELP Committee and was never brought to the Senate floor.

Senator Orrin Hatch remains as the head of the Finance Committee and will be a key player in repealing/replacing the Affordable Care Act. Regardless of your insurance status, the ACA repeal/replacement will impact all people with diabetes.

What Should We Expect The First Few Weeks of the 115th Congress for Diabetes?

It won’t be boring. The Affordable Care Act (Obamacare) has been selected as a rallying point for the new administration. While the ACA can’t be repealed fully during the first few weeks, we can expect that the Republican majority House and Senate to use a concept called “reconciliation” to strip some of the budgetary portions of the Act.

Created by the Congressional Budget Act of 1974, reconciliation allows for expedited consideration of certain tax, spending, and debt limit legislation.  In the Senate, reconciliation bills aren’t subject to filibuster and the scope of amendments is limited, giving this process real advantages for enacting controversial budget and tax measures. (http://www.cbpp.org/research/federal-budget/introduction-to-budget-reconciliation)

With reconciliation, the Senate could pass legislation to repeal parts of the bill with 51 votes, avoiding a filibuster. If it’s attached to the nation’s budget, then it can be reconciled. Individual and company mandates to purchase insurance can be repealed, as the tax subsidies given to Marketplace policies.

What cannot be repealed through reconciliation is the pre-existing condition protection and the ability to keep children on a policy until the age of 26. 

For people with diabetes, these two issues are incredibly important.

Over the next several weeks and months, bills will be presented to replace the Affordable Care Act. DPAC will be reviewing these bills to ensure that our community has access to safe and quality medical devices, medications, supplies, and services.

Happy Birthday, 115th Congress! We’ll be watching you grow!

This Election is Over. Now What?

This was an interesting election year, was it not?

Senate

34 of the 100 seats in the Senate were up for grabs.

U.S. Senate Partisan Breakdown before and after the 2016 Election from Ballotpedia.
U.S. Senate Partisan Breakdown before and after the 2016 Election from Ballotpedia.

House

All 435 seats in the House of Representatives were in play for the election. (Musical chairs, anyone?)

U.S. House Partisan Breakdown before and after the 2016 Election
U.S. House Partisan Breakdown before and after the 2016 Election

 

Regardless of your political affiliation, the nail biter evening brought surprises for many. Now that it’s over and the new Administration and Congress are vowing to bring sweeping changes to healthcare, you might be asking how those changes might impact you.

Affordable Care Act

If you are one of the millions who have benefited from the Affordable Care Act, nothing will change for 2017. Enrollment for the 2017 coverage year will continue and according to many, you will not lose your healthcare coverage you’ve purchased on the Exchange for 2017.

What does that mean to you right now?

Enroll if you need healthcare coverage right now. You have until December 15 to make your application and payment to be covered starting January 1, 2017. Use the information that Dr. Edmund Pezalla provided to DPAC Insiders on his Ask An Expert presentation about Commercial Health Plans for people with diabetes. If you have questions regarding what would be covered under a particular plan, contact a local broker and get the answers or call the plans directly.

What does that mean to you in the future?

Great question. DPAC will be monitoring this issue closely, as we expect action to be taken by the 115th Congress immediately after inauguration. In fact, according to Kellyanne Conway, President-Elect Trump’s campaign manager, he is contemplating holding a “special session” of Congress to immediately repeal ACA.

While it’s unlikely that there will be an immediate impact to the U.S. public, this issue will intensify and polarize Congress over the next several months.

While DPAC recognizes that the Affordable Care Act has flaws, a full repeal without a reasonable solution puts millions of Americans at risk.

You can sign up for DPAC’s Insider Emails to get updates on the ACA issue. 

All Those Bills for Diabetes? Not Going Anywhere.

A special thanks to our community, which includes advocates from JDRF, ADA, AADE, and AACE. We believe that by working together, we get more done. And this Congress, we definitely saw that.

While we saw unprecedented support for the CGM Medicare Act of 2015 and the National Diabetes Clinical Care Commission Act in this Congress, the expectation is that neither bill will be brought to a House vote. (Hope springs eternal, but this lame duck session isn’t looking too springy.)

What does that mean to you right now?

We shouldn’t give up. There are still a few days that Congress will meet and have the opportunity to pass legislation, so there’s no better time than right now to send a message about these two bills.

Here. Click these images and send a message… right now.

CGM Medicare Access Act of 2015

 

National Diabetes Clinical Care Commission Act

Print

What does that mean to you in the future?

New Congress and new opportunities. Many of those who have already co-sponsored will return for the 115th Congress, and we will be pushing them to co-sponsor these bills when they are reintroduced.

This, of course, will also require our community to educate the newer members of Congress. DPAC and other organizations have several ways to do that, so stay tuned. Once January rolls around, we’ll be on it.

Now What?

Our community is passionate, intelligent, and committed. The incoming legislators may not quite understand what diabetes is (and what it isn’t), but they do understand numbers – budgetary numbers and the number of constituents who contact them to make diabetes a priority for policy.

Roll up your sleeves, DPAC Insiders. We have work to do.

Special Diabetes Program

Lexicon for Diabetes Policy Advocacy

 

Diabetes Policy Advocacy Lexicon

Who has time to learn all the definitions of governmental advocacy? We do and so do you! With this simple lexicon, we’re sharing what you need to know to take action today!


Act: Legislation that is proposed that is comprised of many components. A few diabetes related acts are:

Medicare CGM Access Act
National Diabetes Clinical Care Commission Act
Access to Quality Diabetes Education Act


Advocacy
: Using your voice to speak out on a specific issue or topic that concerns you. This can come in many forms (emails, letters, phone calls, face to face meetings, social media posts, etc.) The way you advocate may vary, but taking action is what counts. Any action you take to raise awareness about diabetes and diabetes policies is advocacy.

Amendment: A change to a bill that will then be discussed and voted on the same way a bill is. These changes typically come during the time that a bill is in a committee or sub-committee.

Bill
: Proposed legislation that does not become a law until it is considered and passed by the legislature. Unfortunately, a lot of diabetes related bills can get lost in the shuffle. In the House, a bill will have a number assigned to it, beginning with H.R. (for House of Representatives). For instance, H.R. 1427 is the Medicare CGM Access Act of 2015. A bill introduced in the Senate begins with S. (for Senate).


Committee
: Group of legislators that create legislation on specific topics. For example, S. 586 is currently in the Senate Committee on Health, Education, Labor, and Pensions. Act now to help get S. 586 approved by the Committee.

Congressional Record: The official transcript of federal House and Senate proceedings. You can search for Congressional Records here.

Conference Committee: The House and Senate appoint members to a conference committee to resolve differences between versions of legislation passed by both bodies. Both chambers then vote the combined legislation, which is called a “conference report.”

Co-sponsor: Although a legislator is not the sponsor of a bill, they may still support it and become a cosponsor of that legislation. It is important to have as many cosponsors on a bill. Find out if your elected officials are currently co-sponsoring diabetes related legislation. If not, Tweet them to ask them to co-sponsor.

Direct Lobbying: Actions taken to attempt to influence legislators to vote a specific way on a piece of legislation.

District: The geographic area from which a U.S House member or state legislator is elected. You can find the elected official for your district here.


General
Accounting Office (GAO): GAO is a nonpartisan agency that is often called the “Congressional Watchdog” as they investigate how all taxpayer dollars are spent by the federal government. Since Medicare is funded by taxpayer dollars, this is an important agency for people with diabetes.


DPACActNowBubbleGrassroots Lobbying
: Attempts to influence legislators on a specific legislation by affecting the public opinion and asking the public to take action. Sound familiar?

Hearing: A meeting to be able to present specific points of view to a committee. These meetings could include specific evidence, experts in the field or even members of public that may be affected by the outcome of the bill. Recently, Congressman Lipinski revealed his CGM and pump during a Congressional Hearing.

House: The lower body of the Congress, and most state legislatures. House members are elected to represent a geographic district. The US House (435 voting members) is much larger than the Senate (100 members).

Information Advocacy: Activities to provide useful information that may be used to create policy. Personal stories that are shared to your elected officials help provide information as to why certain legislation is so important to people with diabetes.

Judicial Advocacy: The attempt to create policy change based on the outcomes of the legal system.

Legislative Advocacy: The attempt to change policy from a legislative perspective. This could include lobbying for or against a bill, new legislation or even amendments to current bills. We encourage you to ask Congress to suspend the CMS Competitive Bidding Program, which would be a form of legislative advocacy.


Legislative
Assistant (LA): A member of the staff that is put in charge of a specific issue or area. This person may be the most important person that you can speak to in an elected officials office. If you have the opportunity to speak with any staff member about diabetes related legislation, please do.

Lobbying: The act of attempting to influence legislators decision on a specific topic.


Majority (Minority) Leader
: Leader of the majority (minority) party in either the House or the Senate:

Majority (Republican) Leader House – Kevin McCarthy – Diabetes Caucus Member
Minority (Democratic) Leader House – Nancy Pelosi – Diabetes Caucus Member
Majority (Republican) Leader Senate – Mitch McConnell
Minority (Democratic) Leader Senate – Harry Reid


Mark-up
: The process of reviewing and potential revisions to a particular part of legislation by the committee members. There are several diabetes related bills that are currently in the mark-up phase. Please find your elected official on the DPAC Scorecard and Tweet your official.

Rider: When a specific bill has a great amount of strength, a provision may be attached to that bill in order to “ride” along through the approval process.

Whip: A chosen legislator whose job is to enforce their party’s policy by encouraging all members to vote a specific way:

Majority (Republican) Whip House – Steve Scalise – Diabetes Caucus Member
Minority (Democratic) Whip House – Steny Hoyer – Diabetes Caucus Member
Majority (Republican) Whip Senate – John Cornyn
Minority (Democratic) Whip Senate – Richard Durbin – Diabetes Caucus Member

 

Get Personal with Policy Makers

While facts and figures are important when you are talking with policy makers, nothing is more powerful than a personal story. Real life stories help representatives know how their actions directly impact their constituents.

How Can You Get Personal?

Daily Life

Explain what your daily life is like living with diabetes. You may not have a lot of time, so you have to pick and choose what your share, but give a summary of some of the activities that you must do on a daily basis. Prepare this story before you head into the meeting. Time yourself and try to keep it as short as possible, but do not leave out important details. Explain how frequently you need to test your blood sugar, how many times you need to take insulin, why accuracy matters in those activities and if you have one, how a CGM works in your life.

How Legislation Affects Your Life

After describing what you have to do everyday to manage your diabetes, explain how current bills can help you manage even better. For example, if you are on Medicare, explain why the Medicare CGM Access Act is important to get passed. Your personal story of why a CGM would lead to better health for you will have a better chance of resonating with your representative. Your story about how a CGM could potentially save your life, but not having access to it because you are on Medicare, puts a face to the bill as opposed to just dollar and cents.

Thank Them

If your elected official has sponsored or co-sponsored any key legislation that is diabetes related, then thank them for doing so. In fact, thank them as soon as the meeting starts, in the middle and when you leave the meeting. Showing your thanks and appreciation goes a long way ith elected officials. Remember, they are hearing a lot of complaints every day.

Don’t Forget the Ask

Sharing your personal story and relating it to diabetes related legislation will take up almost all of your time for your meeting. You can’t forget the reason you are there, the ask. After your personal story was shared, your ask is now not just for a statistic about diabetes, it is for a specific individual that lives within their district.

DPACActNowBubbleNow that you have a few tips on how to share your personal story with your locally elected officials, it is time to schedule time to meet with them. First, you can use our Elected Officials Lookup Tool in order to find the names of all your representatives. Once you have that information, you can go directly to each of their websites to figure out how to schedule an appointment.

Please keep in mind, that you may not meet directly with your representative, but there are plenty of other very important people in the office.

Special Diabetes Program

Important People in Your Elected Official’s Office

One of the important efforts in diabetes advocacy is setting up time to meet with your elected officials. It is also important to understand who the key people are in the office. The staff that works in the office are the ones who can directly communicate with your elected official.

The size of the staff differs between the Senate and House. Senators’ staff can range from as low as 20 to as high as 60. A House member is only allowed 18 full-time positions and 4 part-time positions.

Congressional Staff is broken up into a few categories:

  • – Personal Staff
  • – Committee Staff
  • – Leadership Staff
  • – Institutional Staff
  • – Support Agency Staff

The people who you may see in the office and are the ones who may be beneficial to your advocacy efforts would be part of the Personal Staff.

Personal Staff

The main role of the personal staff is to provide value and service to the people directly living in an elected officials district. It is likely that communications you receive via e-mail newsletter, printed letters, updates, etc. are coming from the personal staff. The personal staff may also be split between Washington D.C. and the home district. All offices are different, however, it is typical for each office to have the following:

Receptionist / Staff Assistant

The receptionist would be the person that handles incoming phone calls and emails. This could very well be your very first point of contact with your Member’s office, so establishing a friendly relationship could go a long way.

Executive Assistantcalendar-1568148

The executive assistant manages the Member’s schedule and may be the decision maker on who sees or does not see the Member. If you have the opportunity to speak with the executive assistant, this could be your way to get an additional meeting scheduled with a legislative director or assistant, or even the Member themselves.

 

Legislative Correspondents (LC)

LC’s would be the person in charge of responding to emails, letters and drafting responses. Many times your emails and letters are responded to with pre-written emails. Do not get discouraged by this, any response is a good response.

Legislative Director (LD)

The legislative director is responsible for keeping all legislative related items on task and to keep things moving along. The LD can be a key factor in whether or not a member of Congress sponsors or cosponsors a bill. This means that it could be just as important to speak with the LD as it is to speak with the actual member of Congress. Sharing your story with the legislative director about why certain diabetes related legislation can help change your life is an excellent form of advocacy.

Legislative Assistant (LA)

Legislative assistants play a crucial role in advocating for diabetes. LA’s are responsible for monitoring the activity of a bill while in the committee phase. Continued communication with an LA about specific legislation could help ensure that the bill doesn’t get lost in the shuffle. They may also be assigned to writing speeches, meeting with lobbyists and special interest groups, as well as meeting with advocacy groups. Depending on the office, there may be several LA’s assigned to very specific items in order to keep them laser focused on that legislative item.

Chief of Staff (COS)

The Chief of a Staff is in charge of the entire staff. Since all the staff reports to the COS, they are knowledgable in all subject matters. This means that the Member of Congress relies heavily on the COS to keep them informed and updated on all political items within the District and D.C.

District / State Director

The State or District director is in charge of managing the local office and maintaining a relationship with local community leaders and advocates.

DPACActNowBubbleAs you can see, there are a lot of people working in an elected official’s office. Having the opportunity to meet and speak with any one of them in the office is a great starting point. Do not feel discouraged if you cannot meet with your actual elected official. As we mentioned above, there are staff members who are influential in the decisions made by the elected official.

We would love for you to share your story about meeting with your local official or a staff member of theirs. It is important for us to share these stories so we can help encourage each other to do this. The more voices we can make heard, the better. Please share your story either in the comments below or on our Facebook page.

If you have not met with your officials yet, then now is a great time to get started. Simply go to our elected officials lookup tool to find out who your elected officials are. Once you know who your elected officials are, you can then begin the process of scheduling a visit.

May Thank You Tweets

Say Thanks!

DPACActNowBubbleIt is good manners to say thanks when an elected officials co-sponsor bills that help people with diabetes. It also helps them know we are paying attention.

Here’s a list of people who have recently co-sponsored a bill this month. To say “Thank You.” Just click to Thanks! Tweet.

Want to see more than just May’s bill co-sponsors? Click ACT NOW DPAC for our scorecard to tweet any or all the cosponsors.

Diabetes Clinical Care Commission Act

  • Thanks! Sen. Vitter, David [R-LA] 5/23/2016
  • Thanks! Sen. Menendez, Robert [D-NJ] 5/19/2016
  • Thanks! Rep. Walden, Greg [R-OR-2] 5/19/2016
  • Thanks! Rep. Blum, Rod [R-IA-1] 5/18/2016

Medicare CGM Access Bill

  • Thanks! Rep. Butterfield, G. K. [D-NC-1] 05/25/2016
  • Thanks! Rep. Boustany, Charles W., Jr. [R-LA-3] 05/24/2016
  • Thanks! Sen. Udall, Tom [D-NM] 05/23/2016
  • Thanks! Sen. Burr, Richard [R-NC] 5/12/2016
  • Thanks! Rep. Posey, Bill [R-FL-8] 5/10/2016
  • Thanks! Rep. Cook, Paul [R-CA-8] 5/10/2016
  • Thanks! Rep. Richmond, Cedric L. [D-LA-2] 5/10/2016
  • Thanks! Sen. Carper, Thomas R. [D-DE] 05/16/2016

Diabetes Education

  • Thanks! Rep. Maloney, Carolyn B. [D-NY-12] 05/17/2016

Thank You

Say Thanks!

DPACActNowBubbleAll of our efforts of reaching out to our elected officials to ask them to sponsor or co-sponsor bills that help people with diabetes matter. So does saying Thanks when they actually do it.

This list below is an on-going list of people who have recently co-sponsored a bill it worth taking the time to say, “Thank You.” Just click to Thanks! Tweet.

Medicare CGM Access Bill

House

  • Thanks! Rep. Posey, Bill [R-FL-8] 5/10/2016
  • Thanks! Rep. Cook, Paul [R-CA-8] 5/10/2016
  • Thanks! Rep. Richmond, Cedric L. [D-LA-2] 5/10/2016
  • Thanks! Rep. Edwards, Donna F. [D-MD-4] 4/28/2016
  • Thanks! Rep. Miller, Candice S. [R-MI-10] 04/27/2016
  • Thanks! Rep. Huizenga, Bill [R-MI-2] 04/27/2016
  • Thanks! Rep. Long, Billy [R-MO-7] 04/27/2016
  • Thanks! Rep. Johnson, Eddie Bernice [D-TX-30] 04/26/2016
  • Thanks! Rep. Renacci, James B. [R-OH-16] 04/26/2016
  • Thanks! Rep. Blackburn, Marsha [R-TN-7] 04/26/2016
  • Thanks! Rep. Crowley, Joseph [D-NY-14] 04/26/2016
  • Thanks! Rep. Young, Don [R-AK-At Large] 04/26/2016
  • Thanks! Rep. Wittman, Robert J. [R-VA-1] 04/19/2016
  • Thanks! Rep. Knight, Stephen [R-CA-25] 04/19/2016
  • Thanks! Rep. Napolitano, Grace F. [D-CA-32] 04/18/2016
  • Thanks! Rep. Kuster, Ann M. [D-NH-2] 04/18/2016
  • Thanks! Rep. McKinley, David B. [R-WV-1] 04/18/2016
  • Thanks! Rep. Jeffries, Hakeem S. [D-NY-8] 04/18/2016
  • Thanks! Rep. Hensarling, Jeb [R-TX-5] 04/18/2016
  • Thanks! Rep. Sarbanes, John P. [D-MD-3] 04/18/2016
  • Thanks! Rep. Takai, Mark [D-HI-1] 04/13/2016
  • Thanks! Rep. Lawrence, Brenda L. [D-MI-14] 04/13/2016
  • Thanks! Rep. Delaney, John K. [D-MD-6] 04/13/2016
  • Thanks! Rep. Hahn, Janice [D-CA-44] 04/12/2016
  • Thanks! Rep. Perry, Scott [R-PA-4] 04/12/2016
  • Thanks! Rep. Sanchez, Loretta [D-CA-46] 04/12/2016
  • Thanks! Rep. Sessions, Pete [R-TX-32] 04/12/2016
  • Thanks! Rep. Johnson, Sam [R-TX-3] 04/12/2016
  • Thanks! Rep. Poe, Ted [R-TX-2] 04/12/2016
  • Thanks! Rep. Gowdy, Trey [R-SC-4] 04/12/2016
  • Thanks! Rep. Buchanan, Vern [R-FL-16] 04/12/2016
  • Thanks! Rep. Rouzer, David [R-NC-7] 04/12/2016
  • Thanks! Rep. Mullin, Markwayne [R-OK-2] 04/12/2016
  • Thanks! Rep. McMorris Rodgers, Cathy [R-WA-5] 04/12/2016
  • Thanks! Rep. Comstock, Barbara [R-VA-10] 04/12/2016
  • Thanks! Rep. Neal, Richard E. [D-MA-1] 04/12/2016
  • Thanks! Rep. Murphy, Tim [R-PA-18]3/21/2016
  • Thanks! Rep. Duncan, John J., Jr. [R-TN-2]3/21/2016
  • Thanks! Rep. Luetkemeyer, Blaine [R-MO-3]3/21/2016
  • Thanks! Rep. Brooks, Susan W. [R-IN-5]3/21/2016
  • Thanks! Rep. Tipton, Scott R. [R-CO-3]3/17/2016
  • Thanks! Rep. Webster, Daniel [R-FL-10]3/17/2016
  • Thanks! Rep. Clay, Wm. Lacy [D-MO-1]03/16/2016
  • Thanks! Rep. O’Rourke, Beto [D-TX-16]03/16/2016
  • Thanks! Rep. Green, Gene [D-TX-29]03/16/2016
  • Thanks! Rep. Graham, Gwen [D-FL-2]03/16/2016
  • Thanks! Rep. Bishop, Rob [R-UT-1]03/16/2016
  • Thanks! Rep. Reichert, David G. [R-WA-8]03/15/2016
  • Thanks! Rep. Nadler, Jerrold [D-NY-10]03/14/2016
  • Thanks! Rep. Smith, Adam [D-WA-9]03/15/2016
  • Thanks! Rep. Bishop, Sanford D., Jr. [D-GA-2]03/14/2016
  • Thanks! Rep. Palazzo, Steven M. [R-MS-4]02/04/2016
  • Thanks! Rep. Watson Coleman, Bonnie [D-NJ-12]02/01/2016
  • Thanks! Rep. Salmon, Matt [R-AZ-5]02/01/2016
  • Thanks! Rep. Yoho, Ted S. [R-FL-3]01/12/2016
  • Thanks! Rep. Forbes, J. Randy [R-VA-4]01/08/2016
  • Thanks! Rep. Grayson, Alan [D-FL-9]01/08/2016

Senate

  • Thanks! Sen. Whitehouse, Sheldon [D-RI] 4/27/2016
  • Thanks! Sen. Mikulski, Barbara A. [D-MD]03/14/2016

National Diabetes Clinical Care Commission Bill

House

  • Thanks! Rep. Velazquez, Nydia M. [D-NY-7] 04/29/2016
  • Thanks! Rep. Rice, Kathleen M. [D-NY-4] 04/29/2016
  • Thanks! Rep. Babin, Brian [R-TX-36] 04/29/2016
  • Thanks! Rep. Brady, Robert A. [D-PA-1] 04/28/2016
  • Thanks! Rep. Walberg, Tim [R-MI-7] 04/28/2016
  • Thanks! Rep. Conyers, John, Jr. [D-MI-13] 04/28/2016
  • Thanks!  Rep. Kaptur, Marcy [D-OH-9]02/24/2016
  • Thanks! Rep. Rokita, Todd [R-IN-4]01/07/2016

Senate

  • Thanks! Rep. Rouzer, David [R-NC-7] 04/21/2016
  • Thanks! Rep. Miller, Candice S. [R-MI-10] 04/21/2016
  • Thanks! Rep. Van Hollen, Chris [D-MD-8] 04/21/2016
  • Thanks! Rep. Scott, “Bobby” [D-VA-3] 04/15/2016
  • Thanks! Rep. Zeldin, Lee M. [R-NY-1] 04/15/2016
  • Thanks! Rep. Perry, Scott [R-PA-4] 04/15/2016
  • Thanks! Rep. Jones, Walter B., Jr. [R-NC-3] 04/15/2016
  • Thanks! Rep. Deutch, Theodore E. [D-FL-21] 04/15/2016
  • Thanks! Rep. Duncan, John J., Jr. [R-TN-2] 04/15/2016
  • Thanks! Rep. Swalwell, Eric [D-CA-15] 04/15/2016
  • Thanks! Rep. Fitzpatrick, Michael G. [R-PA-8] 04/15/2016
  • Thanks! Rep. Thornberry, Mac [R-TX-13] 03/22/2016
  • Thanks! Sen. Boozman, John [R-AR]03/15/2016
  • Thanks! Sen. King, Angus S., Jr. [I-ME]02/23/2016

These are new cosponsors since January 1, 2016. Please ACT NOW and also send thanks to your elected officials who have sponsored or cosponsored before January 1, 2016.

If you do not see your officials on this list, then go to the Scorecard and find out if they have cosponsored or not.

Skip to toolbar